Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ingredion (INGR) EBT (2016 - 2025)

Ingredion's EBT history spans 17 years, with the latest figure at $207.0 million for Q4 2025.

  • For Q4 2025, EBT rose 36.18% year-over-year to $207.0 million; the TTM value through Dec 2025 reached $974.0 million, up 4.62%, while the annual FY2025 figure was $974.0 million, 4.62% up from the prior year.
  • EBT reached $207.0 million in Q4 2025 per INGR's latest filing, down from $241.0 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $276.0 million in Q1 2024 to a low of -$188.0 million in Q1 2021.
  • Average EBT over 5 years is $183.0 million, with a median of $200.5 million recorded in 2021.
  • Peak YoY movement for EBT: crashed 238.24% in 2021, then soared 199.47% in 2022.
  • A 5-year view of EBT shows it stood at $78.0 million in 2021, then skyrocketed by 58.97% to $124.0 million in 2022, then soared by 41.94% to $176.0 million in 2023, then dropped by 13.64% to $152.0 million in 2024, then soared by 36.18% to $207.0 million in 2025.
  • Per Business Quant, the three most recent readings for INGR's EBT are $207.0 million (Q4 2025), $241.0 million (Q3 2025), and $259.0 million (Q2 2025).